טוען...
Pharmacological inhibition of EZH2 disrupts the female germline epigenome
BACKGROUND: Recently discovered drugs that target epigenetic modifying complexes are providing new treatment options for a range of cancers that affect patients of reproductive age. Although these drugs provide new therapies, it is likely that they will also affect epigenetic programming in sperm an...
שמור ב:
הוצא לאור ב: | Clin Epigenetics |
---|---|
Main Authors: | , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
BioMed Central
2018
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5836460/ https://ncbi.nlm.nih.gov/pubmed/29515677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0465-4 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|